Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
16.01
+0.02 (0.13%)
At close: May 28, 2025, 4:00 PM
16.07
+0.06 (0.37%)
After-hours: May 28, 2025, 4:04 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $785.60 million as of May 28, 2025. Its market cap has decreased by -29.77% in one year.
Market Cap
785.60M
Enterprise Value
502.60M
1-Year Change
-29.77%
Ranking
Category
Stock Price
$16.01
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has decreased from $974.02M to $785.60M, a decrease of -19.34%. That is a compound annual growth rate of -9.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 784.62M | -28.63% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 298.78B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 221.01B |
| AstraZeneca | 218.42B |